4/15
07:30 am
ivvd
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
Low
Report
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
4/12
07:30 am
ivvd
Invivyd Announces CEO Transition
Low
Report
Invivyd Announces CEO Transition
4/7
10:17 am
ivvd
We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate [Yahoo! Finance]
4/5
08:02 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $9.00 price target on the stock.
High
Report
Invivyd, Inc. (NASDAQ: IVVD) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $9.00 price target on the stock.
4/4
04:16 pm
ivvd
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million [Yahoo! Finance]
High
Report
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million [Yahoo! Finance]
4/4
04:01 pm
ivvd
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
Medium
Report
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
3/28
07:27 am
ivvd
Adagio Therapeutics GAAP EPS of -$1.81 [Seeking Alpha]
Neutral
Report
Adagio Therapeutics GAAP EPS of -$1.81 [Seeking Alpha]
3/28
07:09 am
ivvd
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/28
07:00 am
ivvd
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
High
Report
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
3/26
08:13 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $10.00 price target on the stock, up previously from $4.00.
Medium
Report
Invivyd, Inc. (NASDAQ: IVVD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $10.00 price target on the stock, up previously from $4.00.
3/25
09:06 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
High
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
3/22
04:35 pm
ivvd
Invivyd stock soars on FDA EUA for COVID-19 prophylaxis drug [Seeking Alpha]
High
Report
Invivyd stock soars on FDA EUA for COVID-19 prophylaxis drug [Seeking Alpha]
3/22
03:41 pm
ivvd
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial [Yahoo! Finance]
High
Report
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial [Yahoo! Finance]
3/22
03:28 pm
ivvd
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
High
Report
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
3/22
03:14 pm
ivvd
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19 [Yahoo! Finance]
High
Report
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19 [Yahoo! Finance]
3/22
03:04 pm
ivvd
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
High
Report
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
2/12
01:11 pm
ivvd
Invivyd Shares Fall 16% on Going Concern Warning [MarketWatch]
Medium
Report
Invivyd Shares Fall 16% on Going Concern Warning [MarketWatch]
2/5
04:16 pm
ivvd
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference [Yahoo! Finance]
Low
Report
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference [Yahoo! Finance]
2/5
04:02 pm
ivvd
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Low
Report
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference